ProMetic Life Sciences Inc. ABOUT PROMETIC LIFE SCIENCES INC.
ProMetic Life Sciences Inc. (www.prometic.com) is a long established biopharmaceutical company with globally recognized expertise in bioseparation, plasma-derived therapeutics and small-molecule drug development. ProMetic offers its state of the art technologies for large-scale purification of biologics, drug development, proteomics and the elimination of pathogens to a growing base of industry leaders and uses its own affinity technology that provides for highly efficient extraction and purification of therapeutic proteins from human plasma in order to develop best-in-class therapeutics and orphan drugs. ProMetic is also active in developing its own novel small-molecule therapeutic products targeting unmet medical needs in the field of fibrosis, anemia, neutropenia, cancer and autoimmune diseases/inflammation as well as certain nephropathies. Headquartered in Laval (Canada), ProMetic has R&D facilities in the UK, the U.S. and Canada, manufacturing facilities in the UK and commercial activities in the U.S., Europe, Russia, Australia and Asia.

Industries:
Medical/Pharmaceuticals | Biotechnology
Contact Information:
Frederic Dumais
Senior Director, Communications and Investor Relations
ProMetic Life Sciences Inc.
[email protected]
+1.450.781.0115

Latest

Oct 03, 2019, 10:56 ET Prometic Shareholders Approve Name Change to Liminal BioSciences Inc.

LAVAL, QC, ROCKVILLE, MD and CAMBRIDGE, United Kingdom, Oct. 3, 2019 /CNW Telbec/ - Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("Prometic" or the "Company"), a biopharmaceutical company...


Sep 09, 2019, 08:00 ET Prometic Reports First Subject Dosed in Phase I Clinical Study with Single Ascending Doses of PBI-4547

Novel, orally active immuno-metabolic agent Potential therapy for NAFLD/NASH, metabolic syndrome and other liver diseases Fully owned and proprietary to Prometic LAVAL, QC, ROCKVILLE, MD and...


Sep 04, 2019, 08:00 ET Prometic Life Sciences to Present at H.C. Wainwright & Co. 21st Annual Global Investment Conference

LAVAL, QC, ROCKVILLE, MD and CAMBRIDGE, United Kingdom, Sept. 4, 2019 /CNW Telbec/ - Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) (Prometic), a biopharmaceutical company focused on...


Sep 03, 2019, 18:53 ET Prometic Life Sciences Announces Intention to Change Name to Liminal BioSciences Inc.

/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/ LAVAL, QC, ROCKVILLE, MD and CAMBRIDGE, United Kingdom, Sept. 3, 2019 /CNW Telbec/ - Prometic Life Sciences Inc....


Aug 12, 2019, 18:45 ET Prometic reports financial results for second quarter 2019

C$229 (US 173) million of outstanding debt converted into Common Shares C$114 (US$87) million in gross proceeds raised in concurrent financings Internal promotions within the management team for...


Aug 08, 2019, 08:00 ET Correction of previous press release: Prometic to report its second quarter financial results and hold conference call

LAVAL, QC, ROCKVILLE, MD and CAMBRIDGE, UK, Aug. 8, 2019 /CNW Telbec/ - Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) (Prometic), wishes to correct an error in its press release entitled...


Aug 07, 2019, 08:00 ET Prometic to report its second quarter financial results and hold conference call

LAVAL, QC, ROCKVILLE, MD and CAMBRIDGE, United Kingdom, Aug. 7, 2019 /CNW Telbec/ - Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) (Prometic), a biopharmaceutical company focused on developing ...


Aug 05, 2019, 17:40 ET Prometic Life Sciences to Present at Canaccord 39th Annual Growth Conference

LAVAL, QC, ROCKVILLE, MD and CAMBRIDGE, United Kingdom, Aug. 5, 2019 /CNW Telbec/ - Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCD) (Prometic), a biopharmaceutical company focused on developing ...


Jul 02, 2019, 08:30 ET Prometic Announces Share Consolidation

/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/ LAVAL, QC, ROCKVILLE, MD and CAMBRIDGE, UK, July 2, 2019 /CNW Telbec/ - Prometic Life Sciences Inc. (TSX: PLI)...


Jun 19, 2019, 18:58 ET Prometic Announces Voting Results of its 2019 AGM

LAVAL, QC, ROCKVILLE, MD and CAMBRIDGE, United Kingdom, June 19, 2019 /CNW Telbec/ - Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("Prometic" or the "Corporation") announced the voting...


Jun 17, 2019, 08:30 ET Prometic announces completion of equity rights offering

/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/ Full allocation of exercised rights Gross proceeds raised of C$38 million (or US$ 28.4 million) LAVAL, QC,...


Jun 14, 2019, 03:30 ET Prometic Presents New Data on PBI-4050 and its Mechanism of Action on Kidney Fibrosis at the 56th ERA/EDTA Congress

LAVAL, QC, ROCKVILLE, MD and CAMBRIDGE, United Kingdom, June 14, 2019 /CNW Telbec/ - Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) (Prometic), a biopharmaceutical company focused on...


May 30, 2019, 09:00 ET Prometic Life Sciences to Present at Two Upcoming June Investor Conferences

LAVAL, QC, ROCKVILLE, MD and CAMBRIDGE, United Kingdom, May 30, 2019 /CNW Telbec/ - Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) (Prometic), a biopharmaceutical company focused on developing ...


May 22, 2019, 08:30 ET Prometic presents new PBI-4050 and Ryplazim™ (plasminogen) data on lung fibrosis at the 2019 ATS Conference

LAVAL, QC and CAMBRIDGE, United Kingdom, May 22, 2019 /CNW Telbec/ - Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) (Prometic) today announced the presentation of three scientific posters on...


May 15, 2019, 15:08 ET Prometic announces terms of equity rights offering

/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/ LAVAL, QC, May 15, 2019 /CNW Telbec/ - Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("Prometic" or the ...


May 08, 2019, 19:46 ET Prometic reports its 2019 first quarter financial results

Completion of recapitalization transactions and $75 million in gross proceeds secured from equity offering New CEO, Board appointees and management structure to strengthen Corporation's leadership $8....


May 08, 2019, 18:31 ET Prometic strengthens its leadership with a new management structure and the appointment of three new directors

LAVAL, QC and CAMBRIDGE, United Kingdom, May 8, 2019 /CNW Telbec/ - Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("Prometic" or "Corporation") is pleased to announce today a new management...


Apr 23, 2019, 12:33 ET Prometic Completes Refinancing Transactions Including C$75 Million (approximately US$56 Million) in Gross Proceeds from New Equity Financing

Stefan Clulow appointed as Chair of the Board Kenneth Galbraith appointed as Chief Executive Officer /NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/ LAVAL, QC, ...


Apr 15, 2019, 07:00 ET Prometic Announces Refinancing Transactions

/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/ LAVAL, QC, April 15, 2019 /CNW Telbec/ - Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("Prometic" or...


Apr 01, 2019, 18:20 ET Prometic reports fourth quarter and 2018 year-end financial results

Total revenues for 2018 of $47.4 million compared to $39.1 million in 2017 Significant increase in bioseparation 2018 revenues to $22.7 million, a 35% increase over 2017 Net loss of $ 237.9 million...


Mar 26, 2019, 12:32 ET Prometic to Report its Fourth Quarter and 2018 Year-End Financial Results and Hold Conference Call / Webcast

LAVAL, QC, March 26, 2019 /CNW Telbec/ - Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("Prometic" or the "Corporation") announced today that it will report its financial results for the...


Mar 25, 2019, 07:00 ET Prometic secures additional USD $5 million (CAD $6.7 million) tranche from structured Alpha LP, an affiliate of Thomvest Asset Management Inc., under its existing credit facilities

LAVAL, QC, March 25, 2019 /CNW Telbec/ - Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("Prometic" or the "Corporation") announced today that it has secured an additional USD $5 million (CAD...


Feb 25, 2019, 07:00 ET Prometic secures additional USD $10 million (CAD $13.2 million) tranche from Structured Alpha LP, an affiliate of Thomvest Asset Management Inc., under its existing credit facilities

LAVAL, QC, Feb. 25, 2019 /CNW Telbec/ - Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("Prometic" or the "Corporation") announced today that it has secured an additional USD $10 million (CAD...


Feb 14, 2019, 07:00 ET Prometic retains investment bank for strategic transactions

LAVAL, QC, Feb. 14, 2019 /CNW Telbec/ - Prometic Life Sciences Inc. (TSX: PLI), (OTCQX: PFSCF) ("Prometic" or the "Corporation") today announced that it has engaged Lazard to review and execute key...


Dec 19, 2018, 07:30 ET Prof. Simon Best Appointed Interim CEO of Prometic Life Sciences

LAVAL, QC, Dec. 19, 2018 /CNW/ - The Board of Directors of Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("Prometic" or the "Corporation") announced today that it has named Prof. Simon Best...